Form 4 for OFIX Orthofix Medical Inc.

Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001193125-26-094462 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-03-05	2026-03-03	OFIX	Vitale Lucas	CP, BOO	A - Grant	$0.00	+19.2K	167.0K	+13%	$0
D	2026-03-05	2026-03-03	OFIX	Vitale Lucas	CP, BOO	A - Grant	$0.00	+45.5K	45.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-03	A	A	19,186	$0.00	167,030	D	—	—	(F1) Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date. (F2) Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
2	Derivative	Employee Stock Option (Right to Buy)	2026-03-03	A	A	45,546	$0.00	45,546	D	$13.03 · — to 2033-03-03	45,546 Common Stock	(F3) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.